Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Visualizing Single-Stranded DNA During DNA Repair for Therapeutic Insights
Published on: December 22, 2023
Efficient activity of uracil DNA glycosylase (UNG2) in proliferating cells requires binding to proliferating cell
Rashmi S Kulkarni1, Brian P Weiser1
1Department of Cell & Molecular Biology, Rowan-Virtua School of Osteopathic Medicine, Rowan University, Stratford, NJ 08084, United States; Department of Cell & Molecular Biology, Rowan-Virtua School of Translational Biomedical Engineering & Sciences, Rowan University, Stratford, NJ 08084, United States.
Abstract:
The compounds pemetrexed and 5-fluorodeoxyuridine (FdU) are widely used for cancer therapies and disrupt cell proliferation by inducing DNA damage and stressing DNA replication. The drugs disrupt pyrimidine nucleotide metabolism and promote the accumulation of uracil bases in genomic DNA, which are repaired by uracil DNA glycosylase (UNG2) and downstream base excision repair proteins. UNG2 interacts with Proliferating Cell Nuclear Antigen (PCNA) and Replication Protein A (RPA), which localize to the replication fork during DNA damage responses to orchestrate DNA repair. In this work, we tested whether UNG2 requires interaction with PCNA and RPA to repair DNA damage in a colorectal cancer model during treatment with pemetrexed or FdU. We genetically knocked out UNG2 in HT29 cells and engineered the cells to express UNG2 variants that cannot bind to PCNA or RPA. We found that eliminating UNG2 activity or disrupting its interaction with PCNA or RPA sensitized the cells to the DNA-damaging effects of pemetrexed and FdU. The ability of UNG2 to localize to stalled replication forks was impaired when the enzyme could not interact with PCNA or RPA. Finally, disrupting the interaction of UNG2 with PCNA or RPA sensitized the cells to the cytotoxicity of the drugs. We concluded that certain cancers may be sensitized to pemetrexed and FdU by directly inhibiting the enzymatic activity of UNG2, by depleting UNG2 levels in the cell, or by impairing UNG2 function by inhibiting its protein-protein interactions.
Insights
Cancer drugs pemetrexed and 5-fluorodeoxyuridine (FdU) effectiveness increases when uracil DNA glycosylase (UNG2) interaction with PCNA and RPA is blocked. This impairs DNA repair, sensitizing cancer cells to these therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair Mechanisms
Background:
- Pemetrexed and 5-fluorodeoxyuridine (FdU) are chemotherapy agents that induce DNA damage and replication stress.
- These drugs disrupt pyrimidine metabolism, leading to uracil accumulation in genomic DNA.
- Uracil DNA glycosylase (UNG2) repairs uracil in DNA and interacts with Proliferating Cell Nuclear Antigen (PCNA) and Replication Protein A (RPA) at replication forks.
Purpose of the Study:
- To investigate whether UNG2 requires interaction with PCNA and RPA for DNA repair during pemetrexed or FdU treatment in colorectal cancer cells.
- To determine if disrupting UNG2's interaction with PCNA or RPA affects its function and cellular response to these drugs.
Main Methods:
- Genetically knocked out UNG2 in HT29 colorectal cancer cells.
- Engineered cells to express UNG2 variants unable to bind PCNA or RPA.
- Assessed cellular sensitivity to pemetrexed and FdU.
- Examined UNG2 localization to stalled replication forks.
Main Results:
- Eliminating UNG2 activity or disrupting its interaction with PCNA/RPA sensitized cells to pemetrexed and FdU.
- UNG2's localization to stalled replication forks was impaired when PCNA/RPA binding was disrupted.
- Disrupting UNG2-PCNA or UNG2-RPA interactions increased cellular sensitivity to the drugs' cytotoxic effects.
Conclusions:
- UNG2's interaction with PCNA and RPA is crucial for its function in repairing DNA damage induced by pemetrexed and FdU.
- Cancer cells can be sensitized to pemetrexed and FdU by inhibiting UNG2 activity, depleting its levels, or blocking its protein-protein interactions.
More Related Videos
12:19Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
Published on: April 22, 2022
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Negative Regulator Molecules